ArticleBreast cancer research : BCR2022

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

Annamaria Salvati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.